Rapamycin Reduces mTOR Pathway Hyperactivity
S
Shriya from Healthspan (GetHealthSpan Channel)
Anti-AgingMental HealthSupplementsMedical
Story of claim
Rapamycin inhibits mTOR, reducing harmful protein production and preventing beta-amyloid plaque buildup in Alzheimer's models.
- Goal: To use Rapamycin to decrease harmful protein buildup and manage neurodegenerative diseases.
- Proof: Studies show Rapamycin decreases mTOR activity, reducing harmful proteins and plaque in Alzheimer's models.
- Nuances:
- Rapamycin tested in mice shows no plaque clearance but prevents buildup.
- Potential preventative effects in young, non-degenerative mice.
- Impact on Life: Potential to prevent neurodegeneration and maintain cognitive function.
Investments
- Price: Estimated: $200-300 monthly for Rapamycin therapy
- Time: Lifelong treatment might be necessary
- Effort: Requires adherence to prescribed regimen and monitoring
Risks
Possible side effects and long-term impact of Rapamycin use not fully known.
Alternatives
- Other mTOR inhibitors
- Lifestyle changes enhancing brain health
Get Started 🚀
- Consult a healthcare provider about Rapamycin therapy.
- Understand the potential benefits and risks.
- Regularly assess cognitive health and adjust treatment as needed.
Brogevity AI can make mistakes. Check important info.